These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20486930)

  • 1. The use of biochemical and biophysical tools for triage of high-throughput screening hits - A case study with Escherichia coli phosphopantetheine adenylyltransferase.
    Miller JR; Thanabal V; Melnick MM; Lall M; Donovan C; Sarver RW; Lee DY; Ohren J; Emerson D
    Chem Biol Drug Des; 2010 May; 75(5):444-54. PubMed ID: 20486930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphopantetheine adenylyltransferase from Escherichia coli: investigation of the kinetic mechanism and role in regulation of coenzyme A biosynthesis.
    Miller JR; Ohren J; Sarver RW; Mueller WT; de Dreu P; Case H; Thanabal V
    J Bacteriol; 2007 Nov; 189(22):8196-205. PubMed ID: 17873050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The crystal structures of phosphopantetheine adenylyltransferase with bound substrates reveal the enzyme's catalytic mechanism.
    Izard T
    J Mol Biol; 2002 Jan; 315(4):487-95. PubMed ID: 11812124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria.
    Moreau RJ; Skepper CK; Appleton BA; Blechschmidt A; Balibar CJ; Benton BM; Drumm JE; Feng BY; Geng M; Li C; Lindvall MK; Lingel A; Lu Y; Mamo M; Mergo W; Polyakov V; Smith TM; Takeoka K; Uehara K; Wang L; Wei JR; Weiss AH; Xie L; Xu W; Zhang Q; de Vicente J
    J Med Chem; 2018 Apr; 61(8):3309-3324. PubMed ID: 29498517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards Gram-negative antivirulence drugs: new inhibitors of HldE kinase.
    Desroy N; Moreau F; Briet S; Le Fralliec G; Floquet S; Durant L; Vongsouthi V; Gerusz V; Denis A; Escaich S
    Bioorg Med Chem; 2009 Feb; 17(3):1276-89. PubMed ID: 19124251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of inhibitors of 4'-phosphopantetheine adenylyltransferase (PPAT) to validate PPAT as a target for antibacterial therapy.
    de Jonge BL; Walkup GK; Lahiri SD; Huynh H; Neckermann G; Utley L; Nash TJ; Brock J; San Martin M; Kutschke A; Johnstone M; Laganas V; Hajec L; Gu RF; Ni H; Chen B; Hutchings K; Holt E; McKinney D; Gao N; Livchak S; Thresher J
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6005-15. PubMed ID: 24041904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of phosphopantetheine adenylyltransferase.
    Zhao L; Allanson NM; Thomson SP; Maclean JK; Barker JJ; Primrose WU; Tyler PD; Lewendon A
    Eur J Med Chem; 2003 Apr; 38(4):345-9. PubMed ID: 12750020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial Activity.
    Skepper CK; Moreau RJ; Appleton BA; Benton BM; Drumm JE; Feng BY; Geng M; Hu C; Li C; Lingel A; Lu Y; Mamo M; Mergo W; Mostafavi M; Rath CM; Steffek M; Takeoka KT; Uehara K; Wang L; Wei JR; Xie L; Xu W; Zhang Q; de Vicente J
    J Med Chem; 2018 Apr; 61(8):3325-3349. PubMed ID: 29551072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression and purification of Pyrococcus abyssi phosphopantetheine adenylyltransferase from an optimized synthetic gene for NMR studies.
    Nálezková M; de Groot A; Graf M; Gans P; Blanchard L
    Protein Expr Purif; 2005 Feb; 39(2):296-306. PubMed ID: 15642482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The crystal structure of a novel bacterial adenylyltransferase reveals half of sites reactivity.
    Izard T; Geerlof A
    EMBO J; 1999 Apr; 18(8):2021-30. PubMed ID: 10205156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimentally validated novel inhibitors of Helicobacter pylori phosphopantetheine adenylyltransferase discovered by virtual high-throughput screening.
    Cheng CS; Jia KF; Chen T; Chang SY; Lin MS; Yin HS
    PLoS One; 2013; 8(9):e74271. PubMed ID: 24040220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of an allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography, NMR, and calorimetry.
    Crump MP; Ceska TA; Spyracopoulos L; Henry A; Archibald SC; Alexander R; Taylor RJ; Findlow SC; O'Connell J; Robinson MK; Shock A
    Biochemistry; 2004 Mar; 43(9):2394-404. PubMed ID: 14992576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function analysis of glutamine synthetase adenylyltransferase (ATase, EC 2.7.7.49) of Escherichia coli.
    Jiang P; Pioszak AA; Ninfa AJ
    Biochemistry; 2007 Apr; 46(13):4117-32. PubMed ID: 17355124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.
    Yu L; Oost TK; Schkeryantz JM; Yang J; Janowick D; Fesik SW
    J Am Chem Soc; 2003 Apr; 125(15):4444-50. PubMed ID: 12683814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of antibacterial biotin carboxylase inhibitors by virtual screening and fragment-based approaches.
    Mochalkin I; Miller JR; Narasimhan L; Thanabal V; Erdman P; Cox PB; Prasad JV; Lightle S; Huband MD; Stover CK
    ACS Chem Biol; 2009 Jun; 4(6):473-83. PubMed ID: 19413326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of the gene encoding the human phosphopantetheine adenylyltransferase and dephospho-CoA kinase bifunctional enzyme (CoA synthase).
    Aghajanian S; Worrall DM
    Biochem J; 2002 Jul; 365(Pt 1):13-8. PubMed ID: 11994049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition of phosphopantetheine adenylyltransferase from catalytic to allosteric state is characterized by ternary complex formation in Pseudomonas aeruginosa.
    Chatterjee R; Mondal A; Basu A; Datta S
    Biochim Biophys Acta; 2016 Jul; 1864(7):773-86. PubMed ID: 27041211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From bacterial genomes to novel antibacterial agents: discovery, characterization, and antibacterial activity of compounds that bind to HI0065 (YjeE) from Haemophilus influenzae.
    Lerner CG; Hajduk PJ; Wagner R; Wagenaar FL; Woodall C; Gu YG; Searle XB; Florjancic AS; Zhang T; Clark RF; Cooper CS; Mack JC; Yu L; Cai M; Betz SF; Chovan LE; McCall JO; Black-Schaefer CL; Kakavas SJ; Schurdak ME; Comess KM; Walter KA; Edalji R; Dorwin SA; Smith RA; Hebert EJ; Harlan JE; Metzger RE; Merta PJ; Baranowski JL; Coen ML; Thornewell SJ; Shivakumar AG; Saiki AY; Soni N; Bui M; Balli DJ; Sanders WJ; Nilius AM; Holzman TF; Fesik SW; Beutel BA
    Chem Biol Drug Des; 2007 Jun; 69(6):395-404. PubMed ID: 17581233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
    Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
    J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidimensional profiling of CSF1R screening hits and inhibitors: assessing cellular activity, target residence time, and selectivity in a higher throughput way.
    Uitdehaag JC; Sünnen CM; van Doornmalen AM; de Rouw N; Oubrie A; Azevedo R; Ziebell M; Nickbarg E; Karstens WJ; Ruygrok S
    J Biomol Screen; 2011 Oct; 16(9):1007-17. PubMed ID: 21873591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.